Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

The Hemopump™, The First Intravascular Ventricular Assist Device

Wampler, Richard*; Frazier, O. H.

doi: 10.1097/MAT.0000000000000802
Moment in History

Development of durable left ventricular assist devices (LVADs), based on rotary flow blood pumps, began in earnest after the successful implantation of a catheter-mounted axial flow blood pump via intravascular access in 1988. This device, the Hemopump, successfully supported the circulation of a patient in cardiogenic shock secondary to acute rejection of a transplanted heart. Duration of support was 46 hours, resulting in complete recovery of cardiac function and hospital discharge. In effect, this sentinel event demonstrated that continuous-flow blood pumps could be used to support patients in cardiogenic shock. This held true in spite of many widely held paradigms against rotary blood pumps regarding blood damage, diminished pulsatility, and thrombosis. At this writing, 50,000 patients have been implanted with durable LVADs based on rotary blood pumps as a bridge to cardiac transplantation or destination support as long as 10 years.

From the *Oregon Health Sciences University, Portland, Oregon

Texas Heart Institute at Baylor St. Luke’s Medical Center, Houston, Texas.

Submitted for consideration January 2018; accepted for publication in revised form March 2018.

Disclosure: The authors have no conflicts of interest to report.

Correspondence: Richard Wampler, Oregon Health Sciences University, 5360 Barton Road, Loomis, CA 95650. Email:

Copyright © 2019 by the American Society for Artificial Internal Organs